Quantcast

Latest Hybrid cardiac surgical procedure Stories

2014-08-21 08:28:20

3D Model Enables Precision Treatment for Cardiac Conditions in Patients at High-Risk for Surgery ANDOVER, Mass., Aug. 21, 2014 /PRNewswire/ -- Royal Philips (NYSE: PHG AEX: PHIA) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market its precision planning application for Transcatheter Aortic-Valve Implantation (TAVI) treatments. Through 3D imaging, the Philips TAVI application provides interventionalists with pre-procedural, high-precision...

2014-08-14 12:27:46

CoreValve® System Now Available to More U.S. Patients than any Other Transcatheter Aortic Valve MOUNTAIN VIEW, Calif., Aug. 14, 2014 /PRNewswire/ -- El Camino Hospital became one of the first hospitals in California to adopt a new minimally invasive system to treat patients with narrowed, failing aortic heart valves who are considered to be at high risk to undergo surgery. The U.S. Food and Drug Administration (FDA) approved the Medtronic CoreValve(®) System to treat patients with...

2014-07-31 17:32:49

Oxford University Press Data taken from the German Aortic Valve Registry and published in the European Journal of Cardio-Thoracic Surgery A survey, published online in the European Journal of Cardio-Thoracic Surgery, of 13,860 patients who had undergone interventions for aortic valve disease in Germany has revealed that over 80% were in the same or a better state of health one year after the intervention, and was satisfied with the procedural outcome. Aortic stenosis – the...

2014-07-29 23:04:40

Global Cardiac Surgery devices market growth will be driven by extensive technological advancements, especially for transcatheter heart valve devices, reports iData Research Vancouver, BC (PRWEB) July 29, 2014 According to a new report series by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the Global Cardiac Surgery Devices Market will grow to over $8 billion by 2018. This growth will be fueled by extensive technological...

2014-06-05 00:21:14

NATICK, Mass., June 4, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the RESPOND Post Market Registry to assess real world performance of the Lotus(TM) Valve System. The RESPOND Registry will collect data on clinical outcomes and device performance in 1,000 patients implanted at 50 centers around the world. Three patients enrolled in the RESPOND Registry thus far have been successfully implanted with the Lotus Valve System. Dr. Nicolas Van Mieghem and...

2014-04-02 08:34:41

At One Year, Patients Showed Significantly Lower Fatality and Improved Quality of Life HARRISBURG, Pa., April 2, 2014 /PRNewswire-iReach/ -- Results from a groundbreaking study performed at PinnacleHealth were revealed this weekend at the American College of Cardiology's 2014 Scientific Sessions and simultaneously published in The New England Journal of Medicine. (Photo: http://photos.prnewswire.com/prnh/20140402/MN95343) "In patients with aortic valve stenosis, the self-expanding...

2014-03-31 12:28:59

U-M's Dr. Aimee Armstrong reports valve had low rates of narrowing, leakage, and other adverse events, during American College of Cardiology meeting ANN ARBOR, Mich., March 31, 2014 /PRNewswire-USNewswire/ -- The first post-FDA approval study of a non-surgically implanted replacement pulmonary valve showed strong short- and mid-term results for the device in patients with certain congenital heart defects, according to research presented by a U-M pediatric interventional cardiologist...

2013-12-05 23:50:36

Mental performance preserved throughout two years after catheter-based implantation of an aortic valve prosthesis Aortic valve stenosis is the most frequent heart valve defect of older people in Europe – the cause is usually increasing calcification of this important valve. In patients at high and excessive risk, conventional cardiac surgery is often no therapeutic option. For these patients, transcatheter aortic valve implantation (TAVI) remains the only opportunity. However, this...

2013-10-30 14:09:54

Clinical trial finds that COREVALVE reduces rate of death and stroke in sickest patients with aortic stenosis In a clinical trial, a self-expanding transcatheter aortic valve met the key performance objective of reducing death and stroke in patients with severe aortic stenosis at "extreme risk" for surgery. Results of the COREVALVE EXTREME RISK trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related